Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Interferon gamma [EPC]
Fomitopsis Pinicola Fruiting Body is a biological extract classified as an Interferon gamma [EPC] and Lymphocyte Growth Factor [EPC]. It is primarily utilized in clinical settings as a non-standardized food allergenic extract and for its potential immunomodulatory properties.
Name
Fomitopsis Pinicola Fruiting Body
Raw Name
FOMITOPSIS PINICOLA FRUITING BODY
Category
Interferon gamma [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Fomitopsis Pinicola Fruiting Body
Fomitopsis Pinicola Fruiting Body is a biological extract classified as an Interferon gamma [EPC] and Lymphocyte Growth Factor [EPC]. It is primarily utilized in clinical settings as a non-standardized food allergenic extract and for its potential immunomodulatory properties.
Detailed information about Fomitopsis Pinicola Fruiting Body
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Fomitopsis Pinicola Fruiting Body.
Fomitopsis Pinicola Fruiting Body refers to the medicinal extract derived from the Red-Belted Conk, a polypore mushroom common throughout the temperate Northern Hemisphere. In the context of modern pharmacology and the FDA's Established Pharmacologic Class (EPC) system, Fomitopsis Pinicola Fruiting Body is classified primarily as Interferon gamma [EPC], Lymphocyte Growth Factor [EPC], and a Non-Standardized Food Allergenic Extract [EPC]. This classification indicates that the substance is recognized for its ability to modulate the immune system, specifically by influencing the production of cytokines (cell-signaling proteins) and the proliferation of lymphocytes (white blood cells).
Historically, Fomitopsis pinicola has been used in traditional medicine for its purported anti-inflammatory and antimicrobial properties. However, its inclusion in modern clinical databases stems from its role in allergenic testing and its potential as an immunotherapeutic agent. As a 'Non-Standardized' extract, it is important to note that the potency and specific concentration of active metabolites may vary between preparations, necessitating strict clinical oversight during administration. The FDA tracks these extracts under specific National Drug Codes (NDC) when they are used in diagnostic or therapeutic allergenic applications.
The mechanism of action for Fomitopsis Pinicola Fruiting Body is complex and multi-faceted, involving the activation of various pathways within the innate and adaptive immune systems. As an Interferon gamma [EPC] agent, the extract contains bioactive compounds—primarily complex polysaccharides (beta-glucans) and triterpenoids—that interact with pattern recognition receptors (PRRs) on the surface of immune cells such as macrophages and dendritic cells.
At the molecular level, these beta-glucans bind to receptors like Dectin-1 and Complement Receptor 3 (CR3). This binding triggers a signaling cascade that leads to the activation of Nuclear Factor-kappa B (NF-κB), which in turn stimulates the transcription of genes responsible for the production of Interferon-gamma (IFN-γ). IFN-γ is a critical cytokine for innate and adaptive immunity against viral, some bacterial, and protozoal infections. Furthermore, its classification as a Lymphocyte Growth Factor [EPC] suggests that it promotes the expansion and differentiation of T-cells and Natural Killer (NK) cells, enhancing the body's 'surveillance' capabilities against aberrant cells.
The pharmacokinetics of fungal extracts like Fomitopsis pinicola are distinct from small-molecule drugs due to the high molecular weight of their primary active constituents.
Fomitopsis Pinicola Fruiting Body is utilized in several specific clinical contexts:
Fomitopsis Pinicola Fruiting Body is available in several formulations, depending on the intended clinical use:
> Important: Only your healthcare provider can determine if Fomitopsis Pinicola Fruiting Body is right for your specific condition. The use of non-standardized extracts requires precise diagnostic justification and monitoring by an immunology or allergy specialist.
Dosage for Fomitopsis Pinicola Fruiting Body varies significantly based on the formulation and the clinical indication. There is no universal 'standard' dose due to its classification as a non-standardized extract.
The safety and efficacy of Fomitopsis Pinicola Fruiting Body in pediatric populations have not been extensively established.
Specific dosage adjustments for patients with kidney disease have not been established. However, because the metabolites of fungal polysaccharides are cleared renally, healthcare providers may consider a lower starting dose or increased monitoring for patients with a GFR below 60 mL/min/1.73m².
Caution is advised in patients with severe hepatic impairment (Child-Pugh Class C). While the primary polysaccharides do not rely heavily on liver metabolism, the triterpenoid fraction may pose a metabolic burden in cases of liver failure.
Geriatric patients may have a more sensitive immune response or 'inflammaging' (age-related chronic inflammation). Providers typically start at the lower end of the dosing spectrum (e.g., 250-500 mg daily) to assess tolerability.
If a dose is missed, it should be taken as soon as remembered. If it is nearly time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to catch up, as this may over-stimulate the immune response.
Signs of an acute overdose of Fomitopsis Pinicola Fruiting Body may include:
In the event of a suspected overdose, contact a poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on hydration and management of inflammatory symptoms.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or switch between different brands/formulations without medical guidance, as potency varies significantly between manufacturers.
Because Fomitopsis Pinicola Fruiting Body acts as an immunomodulator, most side effects are related to the activation of the immune system.
> Warning: Stop taking Fomitopsis Pinicola Fruiting Body and call your doctor immediately if you experience any of these.
Prolonged use of Fomitopsis Pinicola Fruiting Body (exceeding 6 months) has not been extensively studied. Potential long-term risks include:
No FDA black box warnings currently exist for Fomitopsis Pinicola Fruiting Body. However, clinicians are advised that as a Non-Standardized Food Allergenic Extract, the risk of unpredictable hypersensitivity reactions is significantly higher than with standardized pharmaceuticals.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of complete blood counts (CBC) and liver function tests (LFT) is recommended for long-term users.
Fomitopsis Pinicola Fruiting Body is a potent biological modifier. It should only be used under the supervision of a healthcare professional, particularly when used for its immunomodulatory properties. Patients must be screened for underlying autoimmune disorders or hypersensitivities prior to initiation.
No FDA black box warnings for Fomitopsis Pinicola Fruiting Body.
Healthcare providers should establish a baseline and perform periodic checks of the following:
Fomitopsis Pinicola Fruiting Body generally does not cause sedation. However, if a patient experiences dizziness or flu-like malaise after a dose, they should avoid driving or operating heavy machinery until these symptoms resolve.
Alcohol should be consumed with caution. Alcohol can exacerbate the gastrointestinal side effects of the extract and may increase the risk of liver enzyme elevations. Furthermore, alcohol is an immunomodulator itself and may interfere with the intended therapeutic effect of the Interferon gamma inducer.
There is no known withdrawal syndrome associated with Fomitopsis Pinicola Fruiting Body. However, it is recommended to 'taper' the dose over 1–2 weeks if the patient has been on high-dose long-term therapy to allow the immune system to return to its baseline state without a sudden 'rebound' of inflammatory markers.
> Important: Discuss all your medical conditions, especially any history of cancer, organ transplant, or autoimmune disease, with your healthcare provider before starting Fomitopsis Pinicola Fruiting Body.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as the immunomodulatory nature of this drug creates a wide net of potential biological interactions.
Fomitopsis Pinicola Fruiting Body must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis by a specialist:
Patients who are sensitive to other members of the Fomitopsidaceae family (such as Fomitopsis officinalis) or the Polyporaceae family (such as Reishi or Turkey Tail mushrooms) are highly likely to exhibit cross-sensitivity to Fomitopsis Pinicola Fruiting Body. Clinicians should perform a graded challenge or skin test if sensitivity is suspected.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'cytokine sensitivity' or rare allergic syndromes, before prescribing Fomitopsis Pinicola Fruiting Body.
Pregnancy Category: Not Classified (FDA).
There are no adequate and well-controlled studies of Fomitopsis Pinicola Fruiting Body in pregnant women. Animal reproduction studies have not been conducted. Interferon-gamma plays a complex role in maternal-fetal tolerance; excessive levels of Th1 cytokines are associated with an increased risk of miscarriage or preterm labor. Therefore, Fomitopsis Pinicola Fruiting Body is not recommended during pregnancy. If a patient becomes pregnant while taking this medication, they should contact their healthcare provider immediately to discuss discontinuation.
It is unknown whether the active polysaccharides or triterpenes from Fomitopsis Pinicola Fruiting Body are excreted in human milk. Because many large-molecule biologicals do not pass into milk in significant quantities, the risk may be low, but the potential for the infant to develop a fungal hypersensitivity or altered immune development cannot be ruled out. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients below the age of 12 have not been established. In children, the immune system is still developing, and the use of a Lymphocyte Growth Factor [EPC] could theoretically interfere with normal immune maturation. Use in children should be restricted to diagnostic allergenic testing performed by a board-certified allergist.
Clinical studies have not included sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, elderly patients often have decreased renal function and a higher prevalence of subclinical autoimmune activity.
No specific dose adjustments are provided in the manufacturer's labeling. However, since the renal route is the primary path for the elimination of fungal metabolites, patients with a creatinine clearance (CrCl) < 30 mL/min should be monitored for signs of systemic toxicity, such as persistent flu-like symptoms or gastrointestinal distress.
Fomitopsis Pinicola Fruiting Body should be used with caution in patients with hepatic impairment. While the polysaccharides are not hepatically metabolized, the triterpenoid components are. In patients with Child-Pugh Class B or C impairment, the half-life of these compounds may be prolonged, increasing the risk of side effects.
> Important: Special populations require individualized medical assessment. Never start this medication in a child or elderly patient without a comprehensive review of their current health status and medication list.
Fomitopsis Pinicola Fruiting Body functions as a biological response modifier. Its primary activity is mediated through 1,3-beta-D-glucans and 1,6-beta-D-glucans.
| Parameter | Value |
|---|---|
| Bioavailability | < 5% (Systemic absorption of intact polysaccharides) |
| Protein Binding | Negligible for polysaccharides; 70-80% for triterpenoids |
| Half-life | 24–72 hours (Biological half-life) |
| Tmax | 2–6 hours (for small-molecule metabolites) |
| Metabolism | Intracellular (macrophage) degradation; minimal CYP involvement |
| Excretion | Renal (primary), Fecal (unabsorbed fraction) |
Fomitopsis Pinicola Fruiting Body belongs to the therapeutic class of Immunostimulants and the functional class of Biological Response Modifiers. It is related to other fungal extracts like Lentinan (from Shiitake) and Polysaccharide-K (PSK), though its specific classification as an Interferon gamma inducer is unique to its EPC designation.
Common questions about Fomitopsis Pinicola Fruiting Body
Fomitopsis Pinicola Fruiting Body is primarily used in clinical settings as a non-standardized food allergenic extract for diagnostic testing. Beyond allergy diagnostics, it is classified as an Interferon gamma inducer and Lymphocyte Growth Factor, meaning it is used by some specialists to support or modulate the immune system. In traditional and alternative medicine, it is sometimes utilized for its anti-inflammatory and antimicrobial properties, although these are not FDA-approved indications. It is often found in specialized immunotherapy protocols or as a dietary supplement intended to enhance natural killer cell activity. Always consult a healthcare provider to understand why this specific extract has been recommended for your clinical profile.
The most frequently reported side effects include gastrointestinal issues such as bloating, gas, and mild diarrhea, which often occur as the gut microbiome adjusts to the complex fungal polysaccharides. Many patients also experience 'flu-like' symptoms, including low-grade fever, muscle aches, and fatigue, which are direct results of the drug's action in increasing interferon-gamma levels. Headaches and mild skin itching are also common during the initial phases of treatment. These symptoms are usually transient and subside within a few days of continued use. If these effects persist or worsen, it is important to contact your healthcare provider for a dosage evaluation.
It is generally advised to avoid or strictly limit alcohol consumption while taking Fomitopsis Pinicola Fruiting Body. Alcohol can suppress certain immune functions and stimulate others, which may interfere with the precise immunomodulatory goals of the medication. Additionally, both alcohol and fungal triterpenes are processed by the liver; combining them may increase the risk of elevated liver enzymes or hepatotoxicity. Alcohol can also exacerbate the gastrointestinal side effects, such as nausea or bloating, commonly associated with this extract. For the best therapeutic outcome and to ensure patient safety, discuss your alcohol intake with your prescribing physician.
Fomitopsis Pinicola Fruiting Body is not recommended for use during pregnancy due to a lack of comprehensive safety data. As an Interferon gamma inducer, the drug could theoretically alter the delicate cytokine balance required to maintain a healthy pregnancy, potentially increasing the risk of complications. There are no adequate human or animal studies to confirm its safety for the developing fetus. Most healthcare providers will advise discontinuing the extract if you are planning to become pregnant or are already pregnant. Always seek medical advice before taking any biological extract during pregnancy to avoid unnecessary risks.
The timeline for efficacy depends on the intended use of the extract. For allergenic skin testing, the reaction is almost immediate, typically occurring within 15 to 30 minutes of administration. For systemic immunomodulatory effects, however, the process is much slower; while cytokine signaling changes occur within hours, noticeable changes in immune function or symptom relief may take 2 to 4 weeks of consistent daily use. Some patients may not see the full therapeutic benefit for up to three months. Because the effects are cumulative, it is essential to follow the prescribed dosing schedule strictly and not discontinue the medication prematurely if results are not immediate.
While Fomitopsis Pinicola Fruiting Body does not cause a traditional 'withdrawal' or physical dependence, stopping it suddenly can cause the immune system to revert to its previous state. If you have been taking the extract for a chronic condition, a sudden stop might lead to a 'rebound' of the symptoms the drug was helping to manage. In some cases, healthcare providers recommend a gradual tapering of the dose over one to two weeks to allow the body's cytokine levels to stabilize. Always consult your doctor before stopping the medication to ensure a safe transition. Sudden discontinuation is only required if you experience a severe allergic reaction or other serious side effects.
If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and resume your regular schedule; never take two doses at once to make up for a missed one. Doubling the dose can lead to an over-stimulation of the immune system, potentially causing severe flu-like symptoms or gastrointestinal distress. Consistency is key for immunomodulatory drugs to maintain a steady state of cytokine induction. If you frequently miss doses, consider using a pill organizer or setting a daily reminder on your phone to stay on track with your treatment plan.
Weight gain is not a commonly reported side effect of Fomitopsis Pinicola Fruiting Body. Unlike corticosteroids, which are known to cause weight gain and fat redistribution, this fungal extract works by stimulating specific immune pathways rather than altering metabolic or hormonal balances in a way that promotes fat storage. In fact, some patients may experience slight weight loss if they encounter persistent gastrointestinal side effects like nausea or a reduced appetite. If you notice significant or rapid changes in your weight while taking this medication, you should discuss this with your doctor to rule out other underlying health issues or fluid retention.
Fomitopsis Pinicola Fruiting Body has a high potential for drug interactions, particularly with medications that affect the immune system or blood clotting. It should not be taken with immunosuppressants, as it may nullify their effects, which is especially dangerous for transplant recipients. It may also interact with blood thinners like Warfarin, increasing the risk of bleeding. Because it can affect blood sugar, it may require adjustments to diabetes medications. Always provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are currently taking to avoid dangerous interactions.
Because Fomitopsis Pinicola Fruiting Body is a 'Non-Standardized Food Allergenic Extract' and a biological product, the concept of a 'generic' in the traditional sense does not apply as it does for small-molecule drugs like ibuprofen. Instead, there are various 'brands' or 'preparations' from different manufacturers, each of which may have slightly different concentrations of active polysaccharides and triterpenes. These are often referred to as 'biosimilars' or simply different manufacturer versions of the same extract. It is important not to switch between different brands without consulting your doctor, as the potency and your body's reaction to them may vary significantly.